Pharmacology, Toxicology and Pharmaceutical Science
Alpha2b Interferon
33%
Bone Marrow Suppression
33%
Chemoradiation Therapy
100%
Chemotherapy
100%
Cisplatin
33%
Death
33%
Disease Exacerbation
33%
Diseases
100%
Fluorouracil
33%
Folinic Acid
33%
Head and Neck Cancer
100%
Hydroxycarbamide
33%
Long Term Survival
33%
Mucosa Inflammation
66%
Overall Survival
66%
Primary Tumor
33%
Progression Free Survival
33%
Recurrent Disease
33%
Second Cancer
66%
Survival Rate
100%
Toxicity
100%
Medicine and Dentistry
Bone Marrow Suppression
10%
Chemoradiotherapy
100%
Cisplatin
10%
Death
10%
Disease Exacerbation
10%
Diseases
100%
Fluorouracil
10%
Folinic Acid
10%
Follow up
10%
Head and Neck Cancer
100%
Hydroxyurea
10%
Induction Chemotherapy
100%
Inpatient
10%
Interferon Alfa 2b
10%
Life
10%
Local Therapy
10%
Long Term Survival
10%
Mucositis
20%
Organ
10%
Overall Survival
20%
Patient
100%
Primary Tumor
10%
Progression Free Survival
10%
Recurrent Disease
10%
Second Cancer
20%
Surgery
40%
Survival Rate
30%
Toxicity
30%
Treatment Duration
10%
INIS
cancer
100%
chemotherapy
100%
combined therapy
100%
control
9%
death
9%
diseases
100%
failures
9%
fluorouracils
9%
hydroxyurea
9%
induction
100%
interferon
9%
leucovorin
9%
malignancies
18%
modifications
9%
organs
9%
patients
100%
radiation doses
9%
radiations
9%
risks
9%
surgery
36%
therapy
9%
toxicity
27%
tumors
9%